Colin Giles
Direktor/Vorstandsmitglied bei Morris Animal Foundation
Profil
Colin Giles is currently the Treasurer & Trustee at Morris Animal Foundation.
He previously worked as the Vice President-Clinical & Regulatory Affairs at Nexvet Biopharma Plc and Nexvet Australia Pty Ltd.
He also worked as the Vice President-Veterinary Medicine Pharmaceuticals at Zoetis, Inc. Dr. Giles received his undergraduate and doctorate degrees from The Royal Veterinary College.
Aktive Positionen von Colin Giles
| Unternehmen | Position | Beginn |
|---|---|---|
Morris Animal Foundation
 Morris Animal Foundation Miscellaneous Commercial ServicesCommercial Services Morris Animal Foundation operates as an animal health charity. It helps support the advancement of veterinary medicine and funds veterinary research for companion animals, horses, and wildlife. The company was founded by Mark Morris Sr. in 1948 and is headquartered in Denver, CO. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Colin Giles
| Unternehmen | Position | Ende |
|---|---|---|
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 |
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Technik-/Wissenschafts-/F&E-Leiter | - |
| ZOETIS INC. | Corporate Officer/Principal | - |
Ausbildung von Colin Giles
| The Royal Veterinary College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZOETIS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Morris Animal Foundation
Morris Animal Foundation Miscellaneous Commercial ServicesCommercial Services Morris Animal Foundation operates as an animal health charity. It helps support the advancement of veterinary medicine and funds veterinary research for companion animals, horses, and wildlife. The company was founded by Mark Morris Sr. in 1948 and is headquartered in Denver, CO. | Commercial Services |
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
